Notify me when Paul L Berns files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NMRA | Neumora Therapeutics, Inc. | Common Stock par value $0.0001 per share | 5.1% | $6,334,229 | 8,226,272 | Paul L Berns | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|